This is a development-stage biopharmaceutical company focused on developing and commercializing products to treat diseases associated with inflammation. This stock is trading up 6.4% at $2.12 in recent trading.
Today's Range: $1.98-$2.14
52-week Range: $1.44-$8.89
Three-Month Average Volume: 604,652
From a technical perspective, ANTH is bouncing sharply here, right off its 50-day moving average of $1.95 with light volume. This move is pushing the stock within range of triggering a near-term breakout trade. That trade will hit once ANTH takes out some near-term overhead resistance at $2.22 with high volume.
Traders should now look for long-biased trades in ANTH, if it can sustain a move or close over $2.22 with volume that's near or above 604,652 shares. If we get that action soon, then ANTH could easily hit its April high of $2.75 or possibly even $3 in the near future.